arsenicum album c12 kroglice
adriapharm d.o.o. - arsenicum album - kroglica - arsenicum album 12 c / 1 g - -
arsenicum album c12 kroglice
adriapharm d.o.o. - arsenicum album - kroglica - arsenicum album 12 c / 1 g - -
arsenicum album c200 kroglice
adriapharm d.o.o. - arsenicum album - kroglica - arsenicum album 200 c / 1 g - -
arsenicum album c200 kroglice
adriapharm d.o.o. - arsenicum album - kroglica - arsenicum album 200 c / 1 g - -
arsenicum album c30 kroglice
adriapharm d.o.o. - arsenicum album - kroglica - arsenicum album 30 c / 1 g - -
arsenicum album c30 kroglice
adriapharm d.o.o. - arsenicum album - kroglica - arsenicum album 30 c / 1 g - -
arsenicum album c6 kroglice
adriapharm d.o.o. - arsenicum album - kroglica - arsenicum album 6 c / 1 g - -
arsenicum album c1000 kroglice
arsenicum album - kroglica - arsenicum album 1000 c / 1 g - -
arsenicum album c1000 kroglice
arsenicum album - kroglica - arsenicum album 1000 c / 1 g - -
arsenic trioxide medac
medac gesellschaft für klinische spezialpräparate mbh - arzenov trioksid - levkemija, promyelocytic, akutna - antineoplastična sredstva - arsenic trioxide medac is indicated for induction of remission, and consolidation in adult patients with:newly diagnosed low-to-intermediate risk acute promyelocytic leukaemia (apl) (white blood cell count, ≤ 10 x 10³/μl) in combination with all-trans-retinoic acid (atra)relapsed/refractory apl (previous treatment should have included a retinoid and chemotherapy) characterised by the presence of the t(15;17) translocation and/or the presence of the pro-myelocytic leukaemia/retinoic-acid-receptor-alpha (pml/rarα) gene. odgovor stopnja drugih akutnih myelogenous levkemijo podtipov, da arzenov trioksid, ki še niso bili pregledani.